DK0594837T3 - Præparater med radiomærket forbindelse - Google Patents

Præparater med radiomærket forbindelse

Info

Publication number
DK0594837T3
DK0594837T3 DK93911868.3T DK93911868T DK0594837T3 DK 0594837 T3 DK0594837 T3 DK 0594837T3 DK 93911868 T DK93911868 T DK 93911868T DK 0594837 T3 DK0594837 T3 DK 0594837T3
Authority
DK
Denmark
Prior art keywords
pct
sec
date
compound preparations
radiolabelled compound
Prior art date
Application number
DK93911868.3T
Other languages
English (en)
Other versions
DK0594837T4 (da
Inventor
Roger Price
Christopher May
Elizabeth Buckley
Timothy Stone
Original Assignee
Amersham Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8211352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0594837(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Int Plc filed Critical Amersham Int Plc
Application granted granted Critical
Publication of DK0594837T3 publication Critical patent/DK0594837T3/da
Publication of DK0594837T4 publication Critical patent/DK0594837T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Indole Compounds (AREA)
DK93911868T 1992-04-30 1993-04-27 Præparater med radiomærket forbindelse DK0594837T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92303905 1992-04-30
PCT/GB1993/000869 WO1993022260A1 (en) 1992-04-30 1993-04-27 Radiolabelled compound formulations

Publications (2)

Publication Number Publication Date
DK0594837T3 true DK0594837T3 (da) 1996-04-09
DK0594837T4 DK0594837T4 (da) 2000-03-27

Family

ID=8211352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93911868T DK0594837T4 (da) 1992-04-30 1993-04-27 Præparater med radiomærket forbindelse

Country Status (10)

Country Link
US (1) US5494654A (da)
EP (1) EP0594837B2 (da)
JP (1) JP3117719B2 (da)
AT (1) ATE132842T1 (da)
AU (1) AU655548B2 (da)
CA (1) CA2105402C (da)
DE (1) DE69301300T3 (da)
DK (1) DK0594837T4 (da)
ES (1) ES2081717T5 (da)
WO (1) WO1993022260A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686058A (en) * 1992-04-30 1997-11-11 Amersham International Plc Radiolabelled nucleotide formulations stored in an unfrozen state
FR2727687B1 (fr) * 1994-12-02 1997-01-24 Isotopchim Sarl Stabilisation de composes radiomarques
WO1997001520A1 (en) * 1995-06-28 1997-01-16 E.I. Du Pont De Nemours And Company Composition and method for stabilizing radiolabeled organic compounds
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
HU225723B1 (en) * 2001-03-21 2007-07-30 Izotop Intezet Kft Method for covering of plastic material
HUP0101921A2 (hu) * 2001-05-10 2004-01-28 Izotóp Intézet Kft Radioaktívan jelzett nukleotido/ka/t tartalmazó preparátumok és eljárás azok előállítására

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3261747A (en) * 1964-05-08 1966-07-19 Spencer L Commerford Stabilized iodine labeled 2'-deoxy-5-iodouridine
US3673410A (en) * 1969-06-25 1972-06-27 John H Waite Method of examination of cell samples using a radioactively tagged dye
US4095950A (en) * 1976-06-11 1978-06-20 Bio-Dynamics, Inc. Method for the chromatographic analysis of a technetium-containing mixture
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
DE3274621D1 (en) * 1981-10-30 1987-01-22 Amersham Int Plc Radiopharmaceutical composition based on technetium-99m and reagent for making it
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
JPS59125062A (ja) * 1982-12-29 1984-07-19 Toshiba Corp カラム式免疫分析法
JPS6132291A (ja) * 1984-07-24 1986-02-14 Sony Corp メモリ装置
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
US4966854A (en) * 1986-02-12 1990-10-30 Linus Pauling Institute Of Science And Medicine Radio labelled dye composition for detecting proteins in gels
US5101020A (en) * 1986-02-12 1992-03-31 Linus Pauling Institute Of Science And Medicine Novel radio labeled dyes for detecting proteins in gels
JPS63118661A (ja) * 1986-11-07 1988-05-23 Hitachi Ltd 核酸塩基配列決定装置
JPH0235100U (da) * 1988-08-30 1990-03-06
US4880615A (en) * 1988-11-25 1989-11-14 Merck & Co., Inc. Stabilized radiopharmaceutical compositions
US5262175A (en) * 1989-05-10 1993-11-16 Solanki Kishor K Stabilization of radiopharmaceutical compositions
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats

Also Published As

Publication number Publication date
CA2105402A1 (en) 1993-10-31
AU4266593A (en) 1993-11-29
CA2105402C (en) 2000-04-04
EP0594837B1 (en) 1996-01-10
EP0594837B2 (en) 1999-12-08
AU655548B2 (en) 1994-12-22
DK0594837T4 (da) 2000-03-27
DE69301300T3 (de) 2000-07-27
JP3117719B2 (ja) 2000-12-18
US5494654A (en) 1996-02-27
JPH06502729A (ja) 1994-03-24
ES2081717T3 (es) 1996-03-16
EP0594837A1 (en) 1994-05-04
ES2081717T5 (es) 2000-02-16
DE69301300T2 (de) 1996-05-23
ATE132842T1 (de) 1996-01-15
DE69301300D1 (de) 1996-02-22
WO1993022260A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
TR199900228T2 (xx) �kameli/katk�l� pirido-veya pirimido-i�eren 6,6-veya 6,7-bisiklik t�revler.
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
PL300063A1 (en) 7-(substituted)-9-[(substituted glycil) amido]-6-demethyl-6-deoxy-tetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts and metal complex, pharmaceutical agent and veterinary agent
ATE209186T1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
KR880009910A (ko) 리폭시게네이즈 억제 화합물
CA2232728A1 (en) Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
YU173791A (sh) Indol i benzimidazol-supstituisani imidazol i benzimidazol derivati
DK0594837T4 (da) Præparater med radiomærket forbindelse
DK0632805T3 (da) Melaminderivater til anvendelse i behandlingen af cancer
DE3775198D1 (de) Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide.
NO971997D0 (no) Bruk av immunmodulerende midler
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
MY107263A (en) Dyeing composition for keratin fibers.
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
FI943386A (fi) CNS-aktiivisuuden omaavia tratsodonin alkyylijohdannaisia
ATE107285T1 (de) Neue 3-substituierte pyridinmethanole und diese enthaltende fungizide.
TR199900016T2 (xx) Benzo $g] kuinolin t�revleri.
ATE166870T1 (de) 2-perhalogenalkyl-substituierte benzimidazole, ihre herstellung und ihre verwendung als schädlingsbekämpfungsmittel
ATE265446T1 (de) N-heteroarylmethyl-p-phenylendiamin-derivate sowie diese verbindungen enthaltende oxidationsfärbemittel
KR940014354A (ko) 신규2-페녹시피리미딘유도체,그의제조방법및제초제로서의그의용도
KR950025029A (ko) N-[1-(벤조트리아졸-1-일)]아릴아민 유도체
RS50412B (sr) Derivati tiazofurina
BG50653A1 (en) N- sulphonyl derivatives of 4- nitrophthalimide and method for their preparation